March 8, 2022
NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech company focused on developing an…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: NEC OncoImmunity (NOI)